Differential expression of the human glucocerebrosidase-coding gene

Area of Science:

• Biochemistry
• Genetics
• Cell Biology

Background:

• Gaucher disease is a sphingolipid metabolism disorder caused by deficient glucocerebrosidase (GCase) enzyme activity.
• This deficiency leads to glucocerebroside accumulation, primarily in reticulo-endothelial system cells.
• Clinical heterogeneity and organ-specific manifestations suggest differential gene expression plays a role.

Purpose of the Study:

• To investigate the differential expression of the human GCase gene across various human cell types.
• To determine if GCase gene expression levels correlate with disease manifestations in Gaucher disease.
• To explore potential feedback mechanisms regulating GCase expression.

Main Methods:

• Quantification of GCase-specific mRNA levels using Northern blot hybridization and RNase protection assays in diverse human cell lines.
• Functional analysis of the human GCS gene promoter by transfecting cells with a reporter gene construct (bacterial cat gene).
• Comparison of GCase mRNA levels in Gaucher disease-derived cells versus non-Gaucher cells.

Main Results:

• Significant variation in GCase mRNA levels was observed: high in epithelial cells, intermediate in fibroblasts and promyelocytes, low in macrophages, and barely detectable in B-cells.
• Reporter gene expression driven by the GCS promoter correlated directly with endogenous GCase RNA levels across cell types.
• Gaucher cells consistently showed higher GCase RNA levels compared to their non-Gaucher counterparts.

Conclusions:

• The human GCS gene exhibits highly differential expression across cell types, potentially explaining Gaucher disease's variable clinical presentation.
• GCS gene promoter activity is a key determinant of GCase expression levels in different cells.
• A feedback mechanism, sensitive to enzyme activity, appears to regulate GCase mRNA levels in Gaucher disease.